88 related articles for article (PubMed ID: 15679289)
1. A closer look at Caduet. The new generation of combination treatment.
Brock CM; Pitcock J
Adv Nurse Pract; 2005 Jan; 13(1):31-3. PubMed ID: 15679289
[No Abstract] [Full Text] [Related]
2. Caduet treats two cardiovascular conditions at once.
Wimett L; Laustsen G
Nurse Pract; 2004 Jun; 29(6):56-7. PubMed ID: 15257126
[No Abstract] [Full Text] [Related]
3. Atorvastatin and amlodipine: the successful duet that led to Caduet.
Cardiovasc J Afr; 2009; 20(1):87-8. PubMed ID: 19287825
[No Abstract] [Full Text] [Related]
4. Amlodipine/atorvastatin (Caduet).
Med Lett Drugs Ther; 2004 Jul; 46(1186):56. PubMed ID: 15237282
[No Abstract] [Full Text] [Related]
5. Amlodipine/atorvastatin (Caduet) for preventing heart disease.
Wilson SA; Sanford A
Am Fam Physician; 2006 Mar; 73(6):1067-8. PubMed ID: 16570743
[No Abstract] [Full Text] [Related]
6. Results of a Markov model analysis to assess the cost-effectiveness of a single tablet of fixed-dose amlodipine and atorvastatin for the primary prevention of cardiovascular disease in Korea.
Liew D; Park HJ; Ko SK
Clin Ther; 2009 Oct; 31(10):2189-203; discussion 2150-1. PubMed ID: 19922890
[TBL] [Abstract][Full Text] [Related]
7. Atorvastatin: a new agent for hyperlipidemia.
Kupecz D
Nurse Pract; 1997 Nov; 22(11):87-8, 90, 93. PubMed ID: 9403876
[No Abstract] [Full Text] [Related]
8. Single-pill amlodipine/atorvastatin helps patients of diverse ethnicity attain recommended goals for blood pressure and lipids (the Gemini-AALA study).
Erdine S; Ro YM; Tse HF; Howes LG; Aguilar-Salinas CA; Chaves H; Guindy R; Chopra P; Moller RA; Schou IM;
J Hum Hypertens; 2009 Mar; 23(3):196-210. PubMed ID: 18800143
[TBL] [Abstract][Full Text] [Related]
9. Fixed combination of amlodipine and atorvastatin in cardiovascular risk management: patient perspectives.
Devabhaktuni M; Bangalore S
Vasc Health Risk Manag; 2009; 5(1):377-87. PubMed ID: 19475775
[TBL] [Abstract][Full Text] [Related]
10. Amlodipine/atorvastatin: the first cross risk factor polypill for the prevention and treatment of cardiovascular disease.
Frishman WH; Zuckerman AL
Expert Rev Cardiovasc Ther; 2004 Sep; 2(5):675-81. PubMed ID: 15350169
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous treatment of blood pressure and cholesterol beats the 'SILO' approach in lowering cardiovascular risk: results of the CRUCIAL study.
Aalbers J
Cardiovasc J Afr; 2011; 22(2):101. PubMed ID: 21556456
[No Abstract] [Full Text] [Related]
12. Additive beneficial effects of amlodipine and atorvastatin in reversing advanced cardiac hypertrophy in elderly spontaneously hypertensive rats.
Lu JC; Cui W; Zhang HL; Liu F; Han M; Liu DM; Yin HN; Zhang K; Du J
Clin Exp Pharmacol Physiol; 2009 Nov; 36(11):1110-9. PubMed ID: 19413592
[TBL] [Abstract][Full Text] [Related]
13. Atorvastatin and amlodipine co-treatment in ASCOT--LLA shows benefit.
Cardiovasc J S Afr; 2007; 18(1):43-4. PubMed ID: 17392998
[No Abstract] [Full Text] [Related]
14. A randomized, placebo-controlled trial to evaluate the efficacy, safety, and pharmacodynamic interaction of coadministered amlodipine and atorvastatin in 1660 patients with concomitant hypertension and dyslipidemia: the respond trial.
Preston RA; Harvey P; Herfert O; Dykstra G; Jukema JW; Sun F; Gillen D
J Clin Pharmacol; 2007 Dec; 47(12):1555-69. PubMed ID: 18048574
[TBL] [Abstract][Full Text] [Related]
15. Atorvastatin + amlodipine: new drug. Just a commercial ploy.
Prescrire Int; 2007 Jun; 16(89):105. PubMed ID: 17582926
[TBL] [Abstract][Full Text] [Related]
16. [Analysis of the budget impact for the Spanish National Health System of the fixed combination of amlodipine 5 or 10mg and atorvastatin 10mg].
De Salas M; Fernández De Bobadilla J; Ferro B; Rejas J
Farm Hosp; 2010; 34(4):170-80. PubMed ID: 20382552
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular risk reduction with combination of anti-atherosclerotic medications in younger and older patients.
Athyros VG; Katsiki N; Karagiannis A
Curr Med Res Opin; 2013 Jul; 29(7):791-2. PubMed ID: 23672630
[No Abstract] [Full Text] [Related]
18. Atorvastatin: in the management of hyperlipidaemia.
Ray SK; Rege NN
J Postgrad Med; 2000; 46(3):242-3. PubMed ID: 11298482
[No Abstract] [Full Text] [Related]
19. Can combining different risk interventions into a single formulation contribute to improved cardiovascular disease risk reduction? Rationale and design for an international, open-label program to assess the effectiveness of a single pill (amlodipine/atorvastatin) to attain recommended target levels for blood pressure and lipids (The JEWEL Program).
Hobbs FD; Gensini G; Mancini GB; Manolis AJ; Bauer B; Böhler S; Genest J; Feldman R; Harvey P; Jenssen TG; Metcalfe M; da Silva PM;
Int J Cardiol; 2006 Jun; 110(2):242-50. PubMed ID: 16338012
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous treatment of hypertension and dyslipidaemia may help to reduce overall cardiovascular risk: focus on amlodipine/atorvastatin single-pill therapy.
Cowie MR
Int J Clin Pract; 2005 Jul; 59(7):839-46. PubMed ID: 15963213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
